GlassScriptPhysician profile
Marta M Saj
NPI 1194707521
$2,222.96
in general payments reported to CMS, 2019-2025
31 companies · $48.58 in 2025
The $48.58 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $249 · 2020: $234 · 2021: $242 · 2022: $461 · 2023: $567 · 2024: $420 · 2025: $48.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,036.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,035.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $246.16 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Hologic Sales and Service, LLC | $215.98 | 2019-2025 | Aptima, Acessa Provu System, Fluent Fluid Management System |
| Pfizer INC. | $198.22 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $193.27 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $144.31 | 2023-2024 | |
| Exeltis, USA INC. | $107.27 | 2020-2024 | Slynd |
| Organon LLC | $102.91 | 2021-2024 | Nexplanon |
| Astellas Pharma US INC | $101.21 | 2023 | Veozah |
| Therapeuticsmd, INC. | $85.56 | 2020-2021 | |
| Allergan, INC. | $84.80 | 2019-2020 | |
| Aspira Women'S Health INC | $81.87 | 2021-2022 | |
| Shield Therapeutics INC | $80.45 | 2022-2024 | Accrufer |
| Myovant Sciences INC. | $79.79 | 2022 | |
| Amag Pharmaceuticals, INC. | $66.92 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $54.14 | 2023-2024 | Myfembree |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $50.17 | 2021-2022 | |
| Coopersurgical, INC. | $47.37 | 2019-2023 | Paragard T 380a |
| Kerecis Limited | $43.39 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Gynesonics, INC. | $39.13 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Merck Sharp & Dohme LLC | $26.96 | 2020 | |
| Daiichi Sankyo INC. | $24.13 | 2020 | |
| Exact Sciences Corporation | $22.40 | 2023 | Cologuard Collection Kit |
| Novo Nordisk INC | $17.91 | 2022 | |
| Mylan Pharmaceuticals INC. | $16.27 | 2020 | |
| Covidien LP | $14.69 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.49 | 2019 | |
| Lilly USA, LLC | $14.38 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.88 | 2022 | |
| Vertical Pharmaceuticals, LLC | $12.09 | 2019 | |
| Alfasigma USA, INC. | $11.48 | 2020 | |
| Mission Pharmacal Company | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marta Saj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.